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Abstract: Polyglycidol (or polyglycerol) is a biocompatible polymer with a main chain structure
similar to that of poly(ethylene oxide) but with a –CH2OH reactive side group in every structural
unit. The hydroxyl groups in polyglycidol not only increase the hydrophilicity of this polymer
but also allow for its modification, leading to polymers with carboxyl, amine, and vinyl groups,
as well as to polymers with bonded aliphatic chains, sugar moieties, and covalently immobilized
bioactive compounds in particular proteins. The paper describes the current state of knowledge
on the synthesis of polyglycidols with various topology (linear, branched, and star-like) and with
various molar masses. We provide information on polyglycidol-rich surfaces with protein-repelling
properties. We also describe methods for the synthesis of polyglycidol-containing copolymers and
the preparation of nano- and microparticles that could be derived from these copolymers. The paper
summarizes recent advances in the application of polyglycidol and polyglycidol-containing polymers
as drug carriers, reagents for diagnostic systems, and elements of biosensors.
Keywords: polyglycidol; linear; branched; copolymer; nanoparticles; microparticles; carriers of
bioactive compounds
1. Introduction
Generally, polymers should be chemically stable to ensure the maintenance of their properties
during storage, processing into products, and usage. Typical examples are polyethylene, polypropylene,
and several other vinyl polymers. However, for many applications polymers with special properties
resulting from the presence in their chains of properly selected reactive groups are needed, such as
groups with hydroxyl, carboxyl, aldehyde, and amine functions.
Linear poly(ethylene oxide), one polymer that has found many applications in medicine in
spite of some pros and contras, is sufficiently stable, hydrophilic, and biocompatible; when attached
to surfaces it makes them protein repellent, and provides “stealth” properties to the poly(ethylene
oxide)-modified nanoparticles [1–6]. However, the chains of linear poly(ethylene oxide) cannot have
more than two reactive end-groups, whereas, in many instances, polymers with similar properties,
but bearing multiple functional groups, are needed. Such multifunctional polymers are suitable for
covalent immobilization of various drugs, receptor-targeting moieties, fluorescent labels, and many
other uses.
The closest multifunctional analogue of poly(ethylene oxide) is polyglycidol (see Scheme 1).
The number of hydroxyl –CH2OH groups in the polyglycidol chain is equal to its degree of polymerization.
Thus, polymers with high molar masses provide many options for immobilization and labeling.
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Poly(ethylene oxide) and polyglycidol are used in medicine as protecting and stabilizing 
agents. Direct intravenous or oral administration of many bioactive drug components, particularly 
nucleic acids and almost all kinds of proteins, is ineffective. Various hydrolases and components of 
molecular and cellular immune system induce degradation and elimination of these species from the 
blood. Digestion accompanies oral administration of unprotected nucleic acids and proteins. 
Moreover, even if some large fragments of partially degraded proteins or nucleic acids administered 
orally succeed in crossing the endothelium barrier of the intestine and reaching the blood stream, the 
immune system would degrade them further and eliminate from the organism. Covalent binding of 
poly(ethylene oxide) to proteins and nucleic acids hinders their degradation by protecting them 
from enzymes, antibodies, and macrophages. Thus, modification of proteins, nucleic acids, and their 
carriers by immobilization of poly(ethylene oxide) significantly increases the circulation of these 
species in the blood [1,3,4,6–9]. This process is usually called pegylation (the term is derived from 
poly(ethylene glycol), denoting poly(ethylene oxide) with low molar mass). 
In many instances, the protection of bioactive compounds by pegylation is insufficient. In some 
cases good results were obtained by using liposome or nanoparticle carriers with a protecting 
external layer rich in poly(ethylene oxide). 
Dense grafting of poly(ethylene oxide) strongly increases the hydrophilicity of surfaces, making 
them resistant to protein adsorption and more biocompatible [2,10]. In the case of diagnostic devices, 
the tailored modification of surfaces with poly(ethylene oxide) reduces the uncontrolled, 
adventitious adsorption of proteins, which is important for the specificity of diagnostic tests [5,11].  
Poly(ethylene oxide) is used for many medical applications. However, polyglycidol equipped 
with hydroxyl groups in each polymeric unit opens a way for many others.  
There are thousands of original and review papers devoted to the medical applications of 
poly(ethylene oxide). On the contrary, the knowledge on medical applications of polyglycidol is 
significantly more limited. The aim of this paper is to give an overview of the synthesis of 
polyglycidol and polyglycidol-containing copolymers with varied microstructure and topology and 
some of their medical applications. 
2. Synthesis of Polyglycidol- and Oilyglycidol-Containing Copolymers 
2.1. Monomers 
Glycidol contains two reactive groups in a molecule, epoxide and hydroxyl (Scheme 2). In 
anionic polymerization the epoxide group is involved in propagation, whereas the hydroxyl one is 
responsible for chain transfer reactions. Therefore, the polymerization of glycidol always leads to 
branched polymers. Linear polyglycidol could be synthesized only by polymerization of the 
monomer with blocked –CH2OH groups (e.g., with 1-ethoxyethyl or trityl moieties).  
There are several routes for the synthesis of glycidol (see Scheme 3) [12–21]. Industrial 
production of glycidol is based on the epoxidation of allyl alcohol with hydrogen peroxide or on the 
conversion of glycerol into glycerol monochlorohydrin and its subsequent conversion into glycidol 
under the action of a strong base (e.g., KOH) [12,13]. However, these processes are not 
environmentally friendly, producing significant amounts of harmful waste and causing corrosion of 
equipment. Recently, some researchers concentrated their attention on the much more convenient 
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Poly(ethylene oxide) and polyglycidol are used in medicine as protecting and stabilizing agents.
Direct intravenous or oral administration of many bioactive drug components, particularly nucleic
acids and almost all kinds of proteins, is ineffective. Various hydrolases and components of molecular
and cellular immune system induce degradation and elimination of these species from the blood.
Digestion accompanies oral administration of unprotected nucleic acids and proteins. Moreover, even
if some large fragments of partially degraded proteins or nucleic acids administered orally succeed in
crossing the endothelium barrier of the intestine and reaching the blood stream, the immune system
would degrade them further and eliminate from the organism. Covalent binding of poly(ethylene
oxide) to proteins and nucleic acids hinders their degradation by protecting them from enzymes,
antibodies, and macrophages. Thus, modification of proteins, nucleic acids, and their carriers by
immobilization of poly(ethylene oxide) significantly increases the circulation of these species in the
blood [1,3,4,6–9]. This process is usually called pegylation (the term is derived from poly(ethylene
glycol), denoting poly(ethylene oxide) with low molar mass).
In many instances, the protection of bioactive compounds by pegylation is insufficient. In some
cases good results were obtained by using liposome or nanoparticle carriers with a protecting external
layer rich in poly(ethylene oxide).
Dense grafting of poly(ethylene oxide) strongly increases the hydrophilicity of surfaces, making
them resistant to protein adsorption and more biocompatible [2,10]. In the case of diagnostic devices,
the tailored modification of surfaces with poly(ethylene oxide) reduces the uncontrolled, adventitious
adsorption of proteins, which is important for the specificity of diagnostic tests [5,11].
Poly(ethylene oxide) is used for many medical applications. However, polyglycidol equipped
with hydroxyl groups in each polymeric unit opens a way for many others.
There are thousands of original and review papers devoted to the medical applications of
poly(ethylene oxide). On the contrary, the knowledge on medical applications of polyglycidol is
significantly more limited. The aim of this paper is to give an overview of the synthesis of polyglycidol
and polyglycidol-containing copolymers with varied microstructure and topology and some of their
medical applications.
2. Synthesis of Polyglycidol- and Oilyglycidol-Containing Copolymers
2.1. Monomers
Glycidol contains two reactive groups in a molecule, epoxide and hydroxyl (Scheme 2). In anionic
polymerization the epoxide group is involved in propagation, whereas the hydroxyl one is responsible
for chain transfer reactions. Therefore, the polymerization of glycidol always leads to branched
polymers. Linear polyglycidol could be synthesized only by polymerization of the monomer with
blocked –CH2OH groups (e.g., with 1-ethoxyethyl or trityl moieties).
There are several routes for the synthesis of glycidol (see Scheme 3) [12–21]. Industrial production
of glycidol is based on the epoxidation of allyl alcohol with hydrogen peroxide or on the conversion
of glycerol into glycerol monochlorohydrin and its subsequent conversion into glycidol under the
action of a strong base (e.g., KOH) [12,13]. However, these processes are not environmentally friendly,
producing significant amounts of harmful waste and causing corrosion of equipment. Recently,
some researchers concentrated their attention on the much more convenient approach based on
decarboxylation of glycerol carbonate. Using tetraethylammonium amino acid ionic liquids (TAAILs)
as catalysts allows us to carry out this synthesis in one pot [17,18,20,21].
Polymers 2016, 8, 227 3 of 25
Polymers 2016, 8, 227 3 of 24 
 
approach based on decarboxylation of glycerol carbonate. Using tetraethylammonium amino acid 
ionic liquids (TAAILs) as catalysts allows us to carry out this synthesis in one pot [17,18,20,21]. 
 
Scheme 2. Structure of glycidol and 1-ethoxyethylglycidyl ether. 
 
Scheme 3. Synthetic routes to glycidol. 
The glycidol molecule contains a chiral carbon atom in the ring. Since for some applications the 
enantiomerically pure polyglycidol (or polyglycidol enriched in polymeric units of one enantiomer) 
might be needed, some researchers investigated the stereocontrolled synthesis of glycidol. Already 
in 1991, R. M. Hanson published an extensive review on this subject [12]. The reviewed methods 
included synthesis of the optically active monomers from the optically active substrates (e.g., from 
D-mannitol or L-serine), syntheses by asymmetric epoxidation, enzymatic transformation of achiral 
substrates, and chiral resolution. The latter is especially interesting because it could be based on the 
already synthesized glycidol with blocked –CH2OH groups. Using the properly chosen lipase and 
hydrolysis conditions allowed synthesis of glycidol with nearly 100% enantiomeric purity (see 
Scheme 4) [22]. 
 
Scheme 4. Synthetic pathway to enentiomerically pure glycidol. 
Synthesis of linear polyglycidol requires a monomer with blocked –CH2OH groups. Otherwise, 
the unblocked groups participate in chain transfer, which leads to the branching. Fitton et al. 
described synthesis of glycidol in which the hydroxyls were blocked with 1-ethoxyethyl groups [23]. 
The blocked monomer was synthesized in a simple reaction of glycidol with vinyl ethyl ether. The 
process was catalyzed with p-toluenesulfonic acid (see Scheme 5). 
 
Scheme 5. Synthetic route to 1-ethoxyethylglycidyl ether. 
Scheme 2. Structure of glycidol and 1-ethoxyethylglycidyl ether.
Polymers 2016, 8, 227 3 of 24 
 
approach based on decarboxylation of glycerol carbonate. Using tetraethylammonium amino acid 
ionic liquids (TAAILs) as catalysts allows us to carry out this synthesis in one pot [17,18,20,21]. 
 
Scheme 2. Structure of glycidol and 1-ethoxyethylglycidyl ether. 
 
Scheme 3. Synthetic routes to glycidol. 
The glycidol molecule contains a chiral carbon atom in the ring. Since for some applications the 
enantiomerically pure polyglycidol (or polyglycidol enriched in polymeric units of one enantiomer) 
might be needed, some researchers investigated the stereocontrolled synthesis of glycidol. Already 
in 1991, R. M. Hanson published an extensive review on this subject [12]. The reviewed methods 
included synthesis of the optically active monomers from the optically active substrates (e.g., from 
D-mannitol or L-serine), syntheses by asymmetric epoxidation, enzymatic transformation of achiral 
substrates, and chiral resolution. The latter is especially interesting because it could be based on the 
already synthesized glycidol with blocked –CH2OH groups. Using the properly chosen lipase and 
hydrolysis conditions allowed synthesis of glycidol with nearly 100% enantiomeric purity (see 
Scheme 4) [22]. 
 
Scheme 4. Synthetic pathway to enentiomerically pure glycidol. 
Synthesis of linear polyglycidol requires a monomer with blocked –CH2OH groups. Otherwise, 
the unblocked groups participate in chain transfer, which leads to the branching. Fitton et al. 
described synthesis of glycidol in which the hydroxyls were blocked with 1-ethoxyethyl groups [23]. 
The blocked monomer was synthesized in a simple reaction of glycidol with vinyl ethyl ether. The 
process was catalyzed with p-toluenesulfonic acid (see Scheme 5). 
 
Scheme 5. Synthetic route to 1-ethoxyethylglycidyl ether. 
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T e glycidol molecule contains a chiral carbon atom in the ring. Si ce for some applications the
enantiomerically pure polyglycidol (or polyglycidol enriched in polymeric units of one enantiomer)
might be needed, some researchers investigated the stereocontrolled synthesis of glycidol. Already in
1991, R. M. Ha son published an extensive review on this subject [12]. The re iewed methods included
synthesis of the optically active monomers from the opt cally active substrates (e.g., from D-mannitol
or L-serine), syntheses by asymmetric epox dation, enzymatic transformation of achir l substrates,
and chiral resolution. The latter is especially interesting because i could be based on the already
synthesized glyci ol with blocked –CH2OH groups. Using the properly chose lipase and hydrolysis
conditions allowed synthesis of glycidol with nearly 100% enantiomeric purity (see Scheme 4) [22].
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Synthesis of linear polyglycidol requires a monomer with blocked –CH2OH groups. Oth rwise,
the unblocked groups participate in chain transfer, which leads to the branching. Fitton et al. described
synt sis of glycidol in which the hydroxyls were block d with 1-ethoxyethyl groups [23]. T blocked
mon mer synthesized in a simple reaction of glycidol with vinyl ethyl ether. The process was
catalyzed with p-toluenesulfonic acid (see Scheme 5).
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2.2. Synthesis of Linear Polyglycidol
In 1994 N. Spassky and co-workers provided the first reliable data on the synthesis of linear
polyglicidol with molar masses up to 30,000 [24]. The polymer was obtained by anionic polymerization
of 1-ethoxyethylglycidyl ether (blocked glycidol) initiated with cesium hydroxide and by deblocking
removing protecting groups at acidic conditions.
Mono- and difunctional potassium alkoxides and sec-BuLi/phosphazene base were used later as
initiators [25–30]. However, detailed studies of the anionic polymerization of 1-ethoxyethylglycidyl
ether revealed that in these processes propagation is accompanied by chain transfer, which leads to
polymers with decreased molar masses (see Scheme 6 [28]).
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Polymers with higher molar masses (up to 85,000 for poly(1-ethoxyethylglycidyl ether)
and 53,000 for poly(tert-butyl glycidyl ether)) were obtained by monomer-activated anionic
polymerization initiated with tetraoctylammonium bromide or tetrabutylammonium azide initiators
and a triisobutylaluminum catalyst [29,31]. Deblocking of hydroxyl groups in the abovementioned
polymers gave polyglycidol samples with Mn = 74,000 and 30,200, respectively. The mechanism of
initiation and propagation for the polymerization of 1-ethoxyethylglycidyl ether in a process with
tetrabutylammonium azide initiator and triisobutylaluminum catalyst (monomer activator) is shown
in Scheme 7.
Polymers 2016, 8, 227 4 of 24 
 
2.2. Synthesis of Linear Polyglycidol 
In 1994 N. Spassky and co-workers provided the first reliable data on the synthesis of linear 
polyglicidol with molar masses up to 30,000 [24]. The polymer was obtained by anionic 
polymerization of 1-ethoxyethylglycidyl ether (blocked glycidol) initiated with cesium hydroxide 
and by deblocking removing protecting groups at acidic conditions.  
Mono- and difunctional potassium alkoxides and sec-BuLi/phosphazene base were used later 
as initiators [25–30]. However, detailed studies of the anionic polymerization of 
1-ethoxyethylglycidyl ether revealed that in these processes propagation is accompanied by chain 
transfer, which leads to polymers with decreased molar masses (see Scheme 6 [28]). 
 
Scheme 6. Propagation and cain transfer in the anionic polymerization of 1-ethoxyethylglycidyl 
ether. 
l  ith higher molar masse  (up to 85,000 for poly(1-ethoxyeth lglycid l ether) and 
53,000 for poly(tert-bu yl glycidyl eth r)) wer  obtained by er-activated i i  
l i i  initiated wi h tetraoctylammonium bromide or tetrabutyla monium azide 
initiato s and a triisobutyl luminum catalyst [29,31]. Deblocking f hydroxyl groups in the 
abovementioned polymers gave polyglycidol samples with Mn = 74,000 and 30,200, r sp ctively. The 
mechanism of initiation a d propagation for the polym rization of 1-ethoxy t ylglycidyl ether in a 
process with tetrabutylammonium azide initiator and triisobut laluminum catalyst (monomer 
activator) is shown in Scheme 7. 
 
Scheme 7. Polymerization of 1-ethoxyethylglycidyl ether with tetrabutylammonium azide initiator 
and triisobutylaluminum catalyst (monomer activator). 
. l i ti f - t t l l i l t it t t t l i i i iti t
triis t l l i t l st ( r ti t r).
Polymers 2016, 8, 227 5 of 25
Activation of the monomer molecule with Al(i-Bu)3 leads to formation of a partial positive charge
at the endocyclic –CH2– group, which facilitates the nucleophilic attack during the initiation and
propagation steps.
Polymerization of 1-ethoxyethylglycidyl ether and deblocking of –OH groups is not the only
pathway to creating linear polyglycidol. Other monomers, like trimethylsilylglycidyl ether and
t-butylglycidyl ether, could also be used for this purpose [32]. It is worth noting that t-butylglycidyl
ether is commercially available. However, the advantage of synthesis via polymerization of
1-ethoxyethylglycidyl ether consists is the easy deblocking of –OH groups by removal of acetal
moieties in mildly acidic conditions.
In some instances the difference in deprotection rates for acetal and t-butyl groups could be beneficial.
For example, in Section 2.7 (on functionalized polyglycidol and polyglycidol-containing copolymers) we
discuss the synthesis of polyglycidol derivatives with different labels, based on the selective removal of
acetal and t-butyl groups in poly(1-ethoxyethylglycidyl ether)-b-poly(t-butylglycidyl ether).
2.3. Synthesis of Star-Like Polyglycidol
Polymerization of blocked glycidol with multifunctional initiators leads to star-like polymers,
which after deblocking yield star-like polyglycidols [26,33].
Examples of multifunctional initiators are shown in Scheme 8.
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Scheme 8. Multifunctional initiators used for polymerization of blocked glycidol.
The number of arms in the star-like polyglycidol is equal to the number of hydroxyl groups in the
alcohol used for synthesis of the initiator.
2.4. Synthesis of Branched Polyglycidol
In anionic polymerization of glycidol, the propagation step consists of the nucleophilic attack of
the alkoxide active center on the endocyclic CH2 group and the scission of the CH2–O bond. As a
result, the newly added unit contains the primary hydroxyl side group (see Scheme 9).
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However, the intramolecular chain transfer leads to formation of the primary alkoxide propagating
species (see Scheme 10) [34].
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Because in polymer chains the primary and secondary hydroxyl side groups can be converted
into propagating alkoxide species, branching is inevitable (see Scheme 11) [34]. It is worth noting that
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not all hydroxyl groups participate in the chain transfer leading to branching. Thus, after completion
of the polymerization process and the killing of the active species, the branched macromolecules may
contain primary and secondary hydroxyl groups not only at the chain ends but also along the chains,
inside the branches.
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It has been established that the slow addition of glycidol allows for btaining branched
polymers with a narrow molar mass distribution [35–37]. The following considerations explain
these observations.
Alkoxides of primary and secondary alcohols differ with respect to their reactivity. Thus, a narrow
molar mass distribution is possible only when at any time in each growing macromolecule the primary
and secondary propagating species are present with the same probability, i.e., when for each growing
chain the apparent rate of propagation is the same. Every addition of a monomer molecule leads
to formation of the propagating specie containing an alkox de seconda y alcohol and a primary
hydroxyl side group. Thus, to maintain the same proba ility of –CH2O´ a d =CHO´ in every
macromolecule, the average time between the addition of monomer molecules should be longer than
the time needed for establishing equilibrium between the abovementioned alkoxides. Such conditions
could be assured by slow monomer additions, maintaining low monomer concentration during the
whole polymerization process.
Glycidol also polymerizes by cationic means. Cationic polymerization of oxiranes proceeds
according to the active chain-end (ACE) and/or activated monomer (AM) mechanisms [38].
In polymerization proceeding by ACE mechanism, the active species are tertiary oxonium ions located
at the ends of growing chains. For glycidol, the propagation by the ACE mechanism, independently of
the ring-opening mode during propagation, leads exclusively to polymers with primary side hydroxyl
groups (see Scheme 12).
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Pr pagation according to the AM mechanism co sists of a r actio of protonated mo omer
molecules with the hydroxyl end-groups of the growing chains. Depending on the mode of ring
scission in the activated monomer molecule, the primary and secondary hydroxyl groups are formed.
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A study by S. Penczek et al. revealed that in the cationic polymerization of glycidol initiated with
Brønsted acids the AM mechanism plays an important role [38]. Because activated glycidol also reacts
with hydroxyl groups along the polyglycidol chains, branching is inevitable.
The polymer formed after the complete monomer conversion contains the primary and secondary
hydroxyl groups. The primary hydroxyl groups are the exocyclic groups remaining from the monomer.
The secondary hydroxyl groups are formed as a result of propagation along the pathway, as shown in
Scheme 13.
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2.5. Synthesis of Polyglycidol with Varied Topology by Grafting from the Linear Polyglycidol
Linear polyglycidol containing hydroxyls not only as the end groups but also along the chain could
be functionalized and modified in various ways. Recently Frey discussed this subject in a detailed
manner [32]. Equilibration of low molar mass metal alkoxides with polyglycidol converts some
hydroxyl groups along the polymer chain into alkoxides, which are able to initiate the polymerization
of oxiranes and cyclic esters (see Scheme 14). Alkoxide anions along the polyglycidol chain could also
be formed by contact of the polyglycidol solution with sodium or a potassium mirror. Since reactions
of alkoxide and hydroxyl groups are reversible, a new chain may be grown from practically every
hydroxyl group.
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The structure of the obtained polymer depends on the monomer used for the s nthesis of the grafts.
For example, formation of grafts from linear polyglycidol carried out by polymerization of blocked
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glycidol (e.g., 1-ethoxyethylglycidyl or tert-butylglycidyl ether) yields polymers with a comb-like
structure, whereas grafting of glycidol would result in hyperbranched grafts. The abovementioned
processes are shown in Schemes 15 and 16, illustrating syntheses of polyglycidol with linear and
hyperbranched grafts, respectively.
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2.6. y thesis of olyglycidol- o tai i g opoly ers
e presence of hydroxyl groups (which may b protected or not) in glycidol and glycidol-relate
monomers opens possibilities for the synthesis of a variety f polyglycidol-containing copol mers.
Generally, the possible routes include:
a synthesis of the linear di-block copolymers by polymerization of glycidol with blocked hydroxyl
groups in the process initiated with macroinitiator, i.e., with other polymers containing active
centers at ends of their chains;
b synthesis f the linear di-block copolymers using polyglycidol with blocked hydroxyl groups
along the chain and active end groups, as an initiator for the polymerization of other comonomers;
c synthesis of the linear tri-block copolymers using di-block copolymers with active end groups
(obtained by routes a or b) as macroinitiatiors for the polymerization leading to addition of the
third block;
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d synthesis of the linear tri-block copolymer by polymerization of glycidol with a blocked hydroxyl
group, initiated by a di-functional initiator and using the synthesized di-block macroinitiator for
the polymerization of other monomers, resulting in the addition of new blocks at both ends;
e synthesis of the linear tri-block copolymer in a way similar to route d but by using glycidol with
blocked hydroxyl groups as a second comonomer;
f synthesis of a comb-like copolymer by using polyglycidol (with unprotected hydroxyl groups)
as a macroinitiator and catalyst (e.g., Sn(Oct)2) for polymerization of other comonomers;
g synthesis of the branched copolymer in a way similar to route f but using hyperbranched
polyglycidol as a macroinitiator;
h synthesis of the linear-hyperbranched copolymer in a way similar to route a but using glycidol
(i.e., a monomer with unblocked hydroxyl groups) as a second monomer;
i synthesis of the hyperbranched copolymer by polymerization of glycidol from reactive groups in
the corona of another hyperbranched copolymer.
Schemes 17 and 18 illustrate some of the abovementioned routes.
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Scheme 18. Selected routes leading to copolymers with blocked polyglycidol blocks.
Not all routes shown in Schemes 17 and 18 were verified experimentally. However, taking into
account our present knowledge, they all should allow for synthesis of the desired products. Below are
listed some examples of copolymer s nthesis.
Möller et al. synthesize polystyrene-b-poly l i l in a seq ential polyme ization of styrene and
1-ethoxyethylglycidyl ethe (blocked glycidol) with subsequent deprotection of hy roxyl groups, using
concentrated HCl or acidic ion-exchange resins [39,40]. It should be mentioned that polystyrene nd
polydiene blocks are usually obtained using lithium init ators. This is especially important in the case
of dienes like butadiene and isoprene, when a high content of 1–4 units is required. Polystyrene–Li
and polydiene–Li active species are sufficiently reactive to add epoxide molecules. However, lithium
alkoxides formed as a result of the abovementioned additions are much less reactive and are unable to
add subsequent monomer molecules [41,42]. As a result, the one-pot chain extension of polyvinyl block
with poly(1-ethoxyethylglycidyl ether) is ineffective. Thus, before continuation of the synthesis the
exchange of Li+ for K+ or Cs+ cations is necessary, making the synthesis more tedious. The problem was
solved when the polymerization of epoxides promoted by phosphazene base P(4)-t-Bu (see Scheme 19)
strongly complexing Li+ was developed [43,44].
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Addition of P(4)-t-Bu at the beginning of the synthesis of the second block (i.e., at the beginning of
the polymerization of epoxides) results in the complexation of Li+ cations. Formation of a Li+/P(4)-t-Bu
complex shifts the equilibrium between the covalent lithium alkoxides and the much more reactive
ionic species towards the latter ones. This approach allowed for obtaining polystyrene-b-polyglycidol
copolymers with degrees of polymerization ranging from 40 to 160 and from 70 to 220 for polystyrene
and polyglycidol blocks, respectively [40].
Macroinitiators obtained in the reaction of poly(styrene-co-butadiene-co-isoprene)–OH with
potassium hydride were used for the synthesis of copolymers containing polyvinyl and
poly(1-ethoxyethylglycidyl ether) blocks. The successful deprotection with concentrated HCl yielded
copolymers with polyglycidol blocks [45].
Especially interesting are copolymers containing the hydrophobic biodegradable polyester
and the hydrophilic polyglycidol blocks. These copolymers are considered candidates for the
preparation of drug carriers. To this class belong poly(ethylene oxide)-b-polyglycidol-b-poly(L-lactide)
tri-block copolymers, which were synthesized by a sequential polymerization of ethylene oxide,
1-ethoxyethylglycidyl ether and L-lactide and by deprotection converting acetal groups in
poly(1-ethoxyethylglycidyl ether) into hydroxyl groups (Scheme 20) [46].
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A linear tri-block copolymer with central polyglycidol and side polylactide blocks
was synthesized by one-pot polym rization of 1-ethox ethylglyci yl ether initiated with
HOC(CH3)2CH2CH2C(CH3)2O´K+ (a derivative of 2,4-dimethylhexane-2,4-diol), with subsequent
(when the first monomer was consumed) polymerization of L-lactide [30]. Due to the proton exchange,
L-lactide polymerized at both ends. Deprotection of hydroxyl groups, carried out using AlCl3¨6H2O,
was highly selective. Only the acetal groups were cleaved, leaving the ester groups in the poly(L-lactide)
blocks intact.
It should be noted that in the synthesis of linear copolymers with polyglycidol and polylactide blocks
the sequence of block synthesis is important. At least for K+ counterions, the poly(1-ethoxyethylglycidyl
ether) b ock s uld be synthesized fi st. Th s is because the . . . -CH[CH2OCH(CH3)OCH2CH3]O´K+
growing species, located at the ends f living poly(1-ethoxyethylglycidyl ether), initiate the
polymerization of L-lactide, whereas . . . -C(O)CH(CH3)O-K+ species of living polylactide are inefficient
as initiators of the polymerization of 1-ethoxyethylglycidyl ether. However, such a limitation does not
apply to the copolymerization of tert-butyl glycidyl eter with ε-caprolactione, initiated with benzyl
alcohol/ P(4)-t-Bu system, for which it was possible to obtain random copolymers [47]. Molar masses of
synthesized copolymers were in the range of 13,000 to 49,200. Hydrolysis of t-Bu–O–CH2– groups in
copolymers yielded polyglycidol units.
Pluronic-type copolymers in which polyglycidol constituted the external blocks were also
synthesized [48]. The synthesis began with activation of both ends of the hydroxyl-terminated
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poly(propylene oxide) with CsOH¨H2O. Water produced at this stage was removed by the
addition of dry benzene and azeotropic distillation, yielding a poly(propylene oxide) di-functional
macroinitiator containing Cs+ alcoholate active enters. The macroinitiator initiated polymerization
of 1-ethoxyethylglycidyl ether and the tri-block copolymer—poly(1-ethoxyethylglycidyl ether)-b-
poly(propylene oxide)-b-poly(1-ethoxyethylglycidyl ether) was obtained. Acetal groups in poly(1-
ethoxyethylglycidyl ether) were cleaved with AlCl3¨6H2O, yielding the polyglycidol- b-poly(propylene
oxide)-b-polyglycidol tri-block copolymer.
There are reports on the synthesis of polyglycidol-containing graft copolymers with branched
polyglycidol grafts or with branched polyglycidol cores [49,50].
A polystyrene main chain was synthesized by RAFT copolymerization of styrene and
4-acetoxystyrene initiated by S-1-dodecyl-S”-(α,α’-dimethyl-α”-acetic acid) trithiocarbonate as a
chain-transfer agent [49]. Hydrolysis of acetoxy groups yielded poly(p-hydroxystyrene) units.
The activation of hydroxyl groups with diphenylmethyl potassium (DPMK) yielded a macroinitiator
initiating polymerization of glycidol. At this step the branched polyglycidol grafts were formed.
The process is illustrated in Scheme 21.
Polymers 2016, 8, 227 12 of 24 
 
Pluronic-type copolymers in which polyglycidol constituted the external blocks were also 
synthesized [48]. The synthesis began with activation of both ends of the hydroxyl-terminated 
poly(propylene oxide) with CsOH·H2O. Water produced at this stage was removed by the addition 
of dry benzene and azeotropic distillation, yielding a poly(propylene oxide) di-functional 
macroinitiator containing Cs+ alcoholate active enters. The macroinitiator initiated polymerization of 
1-ethoxyethylglycidyl ether and the tri-block copolymer—poly(1-ethoxyethylglycidyl 
ether)-b-poly(propylene oxide)-b-poly(1-ethoxyethylglycidyl ether) was obtained. Acetal groups in 
poly(1-ethoxyethylglycidyl ether) were cleaved with AlCl3∙6H2O, yielding the 
polyglycidol-b-poly(propylene oxide)-b-polyglycidol tri-block copolymer. 
There are reports on the synthesis of polyglycidol-containing graft copolymers with branched 
polyglycidol grafts or with branched polyglycidol cores [49,50].  
A polystyrene main chain was synthesized by RAFT copolymerization of styrene and 
4-acetoxystyrene initiated by S-1-dodecyl-S’’-(α,α’-dimethyl-α’’-acetic acid) trithiocarbonate as a 
chain-transfer agent [49]. Hydrolysis of acetoxy groups yielded poly(p-hydroxystyrene) units. The 
activation of hydroxyl groups with diphenylmethyl potassium (DPMK) yielded a macroinitiator 
initiating polymerization of glycidol. At this step the branched polyglycidol grafts were formed. The 
process is illustrated in Scheme 21. 
 
Scheme 21. Synthesis of polystyrene with branched polyglycidol grafts. 
The branched polyglycidol core of copolymer with poly(L-lactide) multi-arms was synthesized 
by ring-opening polymerization of glycidol catalyzed/initiated with Sn(Oct)2. The addition of 
D-lactide after complete conversion of glycidol leads to formation of the external poly(L-lactide) 
arms [50]. This copolymerization conforms to route g in Scheme 18, with M denoting D-lactide. 
2.7. Functionalized Polyglycidol and Polyglycidol-Containing Copolymers 
Functionalized polyglycidol could be obtained by the introduction of required functional 
groups during initiation, termination, or as a result of reactions with polyglycidol –CH2OH side 
groups.  
For example, the synthesis of branched polyglycidol with primary amine groups was 
performed in a process that consisted of the following steps [51]:  
• initiation of the polymerization of ethylene oxide with cesium dibenzyl-2-aminoethanolate; 
• using obtained macroinitiator for initiation of the polymerization of 1-ethoxyethylglycidyl 
ether; 
• deblocking of hydroxyl groups in poly(1-ethoxyethylglycidyl ether), activation of hydroxyl 
groups with CsOH; 
• polymerization of glycidol initiated with …–CH2O−Cs+; 
• conversion of the dibenzyl-2-aminoethyl-O–… groups into the NH2CH2CH2O–… groups. 
Details of the synthesis are shown in Scheme 22. 
Scheme 21. Synthesis of polystyrene with branched polyglycidol grafts.
The branched polyglycidol core of copolymer with poly(L-lactide) multi-arms was synthesized by
ring-opening polymerization of glycidol catalyzed/initiated with Sn(Oct)2. The addition of D-lactide
after complete conversion of glycidol leads to formation of the external poly(L-lactide) arms [50].
This copolymerization conforms to route g in Scheme 18, with M denoting D-lactide.
2.7. Functionalized Polyglycidol and Polyglycidol-Containing Copolymers
Functionalized polyglycidol could be obtained by the introduction of required functional groups
during initiation, termination, or as a result of reactions with polyglycidol –CH2OH side groups.
For example, the synthesis of branched polyglycidol with primary amine groups was performed
in a process that consisted of the following steps [51]:
‚ i iti ti f t l ri ti f t l e i e it cesi ibenzyl-2-a inoethanolate;
‚ i obtained macroinit ator for initiation f the polymerization of 1-ethoxyethylglycidyl ether;
‚ deblocking of hydroxyl groups in poly(1-ethoxyethylglycidyl ether), activation of hydroxyl groups
with CsOH;
‚ polymerization of glycidol initiated with . . . –CH2O´Cs+;
‚ conversion of the dibenzyl-2-aminoethyl-O– . . . groups into the NH2CH2CH2O– . . . groups.
Details of the synthesis are shown in Scheme 22.
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In 2010 Möller developed an elegant route for the synthesis of polyglycidol with some blocks 
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Scheme 22. Synthesis of branched polyglycidol with primary amine groups.
It was lso possible to o t in the sulfonate derivative of the abovementioned poly er [51].
The am ne groups in branche polyglycidol, shown in Sch me 22, were further modified by
reaction with 1-pyrene-but ic acid pentaflu rophenyl ester. T reaction resulted in the addition
of the pyrene moiety. The pyrene labels promoted adsorptio of the strongly hydrop ilic, branched
polyglyci ol onto the multi-walled carbon nanotubes, ensuring their solubilization with water [51].
End-capping of the living poly(1-ethoxyethylglycidyl ether) with p-chloromethyl styrene yielded
α-t-butoxy-ω-vinylbenzyl-poly(1-ethoxyethylglycidyl ether), which after deprotection with formic
acid gave α-t-butoxy-ω-vinylbenzyl-polyglycidol [52]. The macromonomer was used as a surfmer,
stabilizing microspheres synthesized in the radical emulsion polymerization of styrene [53].
Functionalization of polyglycidol blocks in the tri-block copolymers (see Scheme 20) was
conveniently performed by esterification of its hydroxymethyl groups with acid chlorides or with
cyclic anhydrides [54]. These functionalization processes are illustrated in Scheme 23.
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Scheme 23. Synthesis of tri-block co olymer with poly(ethylene oxide), polyglycidol and polylactide
blocks with carboxylic acid and 4-(phenyl-azo-phenyl) groups.
In 2010 Möll r develope an elegant route for the synthesis of polyglycidol with some blocks
labele with side C12, C14, and C16 alkyl c ains [55]. The route was based on observation
that in acidic conditions the deblocking of hydr xyl groups in poly(t-bu ylgl cidyl ether)-b-poly
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(1-ethoxyethylglycidyl ether) does not proceed at the same rate. Hydrolysis of acetal groups is much
easier than hydrolysis of t-butyl ether groups. However, it is worth noting that selective deprotection of
hydroxyl groups in random copolymers of t-butylglycidyl ether and 1-ethoxyethylglycidyl ether was
not successful [56]. Apparently, the neighboring group effect facilitated the hydrolysis of t-butyl ether
groups adjacent to the solvated hydroxyls, which were formed by fast hydrolysis of acetal groups [56].
Thus, the synthesis of polyglycidol, in which the units labeled with alkyl chains constituted a separate
block, was performed by the following sequence of reactions:
‚ sequential polymerization of 1-ethoxyethylglycidyl ether and t-butylglycidyl ether initiated with
C6H5–(CH2)3O´K+;
‚ deblocking of hydroxyl groups in poly(1-ethoxyethylglycidol ether) with hydrochloric acid (the
concentration of HCl and time of deblocking were optimized);
‚ labeling of polyglycidol with alkyl chains in reaction between –CH2OH groups of polyglycidol
and alkyl chains with isocyanate end-groups;
‚ deprotection of hydroxyl groups in poly(t-butylglycidyl ether) block using trifluoroacetic acid.
The process of synthesis is illustrated in Scheme 24.
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Scheme 24. Synthesis fof polyglycidol with C12, C14, and C16 alkyl side chains.
Polyglycidol and polyglycidol-containing copolymers could also be conveniently functionalized
by click reaction [56]. The process consists of the addition of propargyl moieties in a reaction of
propargyl bromide with KOH-activated –CH2OH groups of polyglycidol. The obtained poly(glycidyl
propargyl ether-co-glycidol) is ready for further functionalization by Cu(I) controlled (2 + 3)
cycloaddition of compounds with azide groups. Scheme 25 gives an example of the addition of
a sugar moiety.
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Scheme 25. Polyglycidol labeled with sugar moieties.
The above-described modifications of polyglycidol and polyglycidol-containing copolymers
yielded a variety of amphiphilic polymers, which, depending on the details of the structure of the
hydrophilic and hydrophobic components, are often able to self-organize into nanoparticles, liposomes,
and other polymer aggregates suitable for encapsulation or solubilization of hydrophobic compounds.
The presence of reactive groups in polyglycidol and polyglycidol-functionalized derivatives allows
their labeling with fluorescent labels [51,54].
The functional derivatives of polyglycidol can be used as building blocks for the preparation of
nano-objects useful for various applications in medicine.
3. Applications of Polyglycidol and Polyglycidol-Containing Polymers in Medicine
3.1. Biocompatibility
Biocompatibility of polymers is indispensable for using these materials in medicine as drug
carriers, implants (regardless whether permanent or resorbable), and various elements of equipment.
Thus, the issue of the biocompatibility of polyglycidol is of primary importance.
Efficient protein adsorption, accompanied by conformational changes resulting in the
denaturation of adsorbed proteins, usually triggers undesired effects including immune response
and clot formation, and has a deleterious influence on the biological functions of adsorbed proteins.
Extensive studies carried out in our laboratory revealed that the incorporation of polyglycidol into the
interfacial layer of the polystyrene microspheres and surfaces of carbon glass, gold, and stainless steel
flat substrates leads to a strong reduction of protein adsorption [57–62]. However, the activation of
polyglycidol hydroxyl groups with 1,3,5-trichlorotriazine allows for efficient covalent protein binding
(see Scheme 26) [57,59,61,62].
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polyglycerol-based nanogels 
Nanogel swelling in 
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Scheme 26. Attachment of protein to polyglycidol.
Studies of interactions of linear and branched polyglycidols and polyglycidol-containing
copolymers with cell cultures and living organisms revealed that these compounds:
‚ do not interact with the DNA of the Chinese hamster B14 cell line (linear and arborescent polymers
with poly(ethylene oxide) and polyglycidol units) [63];
‚ are not toxic towards peripherial blood mononuclear cells (hyperbranched) [64];
‚ are hemocompatible (hyperbranched polyglycidol and hyperbranched copolymer of glycerol and
sebacic acid) [65,66];
‚ and are well tolerated even if i jected in high doses [65].
It was also found that dendritic polyglycidol with terminal sulfate end groups has
anti-inflammatory properties [67]. These observations support the attempts to use polyglycidols
with various architectures as well as their copolymers as materials for medical applications.
3.2. Polygl cidol-Based Dru Ca riers
Many papers on drug carriers based on polyglycidol and polyglycidol derivatives have already
been published. A comprehensive discussion of particular systems exceeds the scope of this paper.
We will only present a list providing brief information on encapsulated bioactive compounds, the
chemical composition of nano- or micro-carriers, and methods used for their preparation. The data are
listed in Table 1.
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Table 1. Drug carriers based on polyglycidol and polyglycidol derivatives.
Encapsulator
bioactive compound Carrier Method of encapsulation Reference
Proteins
BSA Polylactide-hyperbranched polyglycidol nanoparticles Nanoprecipitation [68,69]
Insulin β-cyclodextrin labeled polyglycidol nanoparticles Coprecipitation [70]
Insulin β-cyclodextrin labeled polyglycidol hydrogel Gelation [71]
Asparaginase Nanogels from dendritic polyglycidols with azide and-p-propargyloxy-benzacetale Inverse nanoprecipitation [72]
transglutaminase 1 Poly(N-isopropylacrylamide)-polyglycerol-based nanogels
Nanogel swelling in
protein solution [73]
Nucleic acids
DNA Quarternized a poly(glycidol-co-ethylene oxide) Nanoprecipitation [74]
pDNA
Quarternized branched
poly(glycidol-co-2,3-epoxypropyldiethyl-amine)
and DNA polyplexes
Incubation of polymer and nucleic
acid solution [75]
siRNA Polyplexes of corona aminated hyperbranchedpolyglycidol and siRNA
Incubation of polymer and nucleic
acid solution [76]
siRNA Polyplexes of hyperbranched polyglycidol modified withglycine and siRNA
Incubation of polymer and nucleic
acid solution [77]
siRNA
Polyplexes of amphiphilic copolymer containing
hyperbranched polyglycidol end-capped with
amines and siRNA
Incubation of polymer and nucleic
acid solution [78]
pDNA
Polyplexes of adamantane-modified hyperbranched
polyglycerol end-capped with cationic
β-cyclodextrin and pDNA
Incubation of polymer and nucleic
acid solution [79]
pDNA
Polyplexes of polyglycidol-pluronic-poly-glycidol with
2-(N,N-dimethylaminomethyl)-5-aminomethyl
phenylboronic acid groups and pDNA
Incubation of polymer and nucleic
acid solution [80]
pDNA
Polyplexes of poly(ethylene oxide)-(branched
polyglycidol) with endgroups capped with
tris(2-aminoethyl)amine)
Incubation of polymer and nucleic
acid solution [81]
pDNA nanodiamond particles with immobilized polyglycidolmodified with grafted poly(arg-co-lys-co-his)
Incubation of nanocarrier and
nucleic acid solution [82]
pDNA and
doxorubicin
hydrochloride
Vesicles composed of cyclodextrin labeled with branched
polyglycidol end-capped with tris(2-aminoethyl)amine)
and bearing aliphatic chains
Nanoprecipitation [83]
DNA Lamin A/C)
and 51-CTGGACTTC
CAGAAGAACATT-3´
Polyplexes of hyperbranched polyglycidol modified by
addition of oligoamines via the photo-cleavable linkages
Incubation of polymer and nucleic
acid solution [84]
Anticancer drugs
Doxorubicin Hyperbranched polyglycidol Covalent immobilization via theenzymatically cleavable linkage [85]
Doxorubicin Hyperbranched polyglycidol with graftedpoly(ethylene oxide)
Covalent immobilization via the
enzymatically cleavable linkage [86]
Doxorubicin Poly(ethylene oxide)-[hyperbranched polyglycidol] Covalent immobilization via pHsensitive hydrazone linkage [87]
Doxorubicin
Hyperbranched polyglycidol with grafted
poly(ethylene oxide) and targeting antibodies agains
epidermal growth factor
Covalent immobilization via pH
sensitive hydrazone linkage [88]
Doxorubicin,
indodicarbocyanine
dye
Hyperbranched polyglycidol
Covalent immobilization of drug
and dye via cleavable linkage.
Monitoring of drug release
by fluorescence
[89]
Doxorubicin Nanodiamond particles with grafted hyperbranchedpolyglycidol end-capped with RGD tripeptide
Covalent immobilization via pH
sensitive hydrazone linkage [90]
Cisplatin Hyperbranched polyglycidol modified withsuccinic anhydride
Covalent immobilization via
carboxyl groups [91]
Cisplatin
Nanodiamond particles with grafted hyperbranched
polyglycidol end-capped with RGD tripeptide and
COOH groups
Covalent immobilization via
carboxyl groups [92]
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Table 1. Cont.
Encapsulator
bioactive compound Carrier Method of encapsulation Reference
Methotrexate Fe3O4 nanoparticles with immobilizedhyperbranched polyglycidol
Covalent immobilization via pH
sensitive hydrazone linkage [93]
Paclitaxel Hyperbranched polyglycidol with sulfate andamine end groups
Covalent immobilization via
cleavable ester linkage [94]
Paclitaxel Hyperbranched polyglycidol with attachedpoly(ethylene oxide) and alkyl chains
Solubilization of
hydrophobic drug [95,96]
Paclitaxel Polymeric micelles of hyperbranched polyglycidol labeledwith β-cyclodextrin Nanoprecipitation [97]
Docetaxel Hyperbranched polyglycidol with attachedpoly(ethylene oxide) and alkyl chains
Solubilization of
hydrophobic drug [96]
Docetaxel Hyperbranched polyglycidol with attached alkyl chains Nanoprecipitation [98]
Sagopilone Hyperbranched polyglycidol with attached alkyl chains Entrapment during micellization [99]
Miscellaneous
Nimodipine Hyperbranched polyglycidol with biphenyl groupsin the core
Solubilization of
hydrophobic drug [100]
Quercetin Polylactide-(hyperbranched polyglycidol) Nanoprecipitation [101]
Endomorphins Hyperbrached polyglycidol modified by addition ofpoly(lactide-co-glycolide) chains
Water-in oil-in water
double emulsification [102]
3.3. Applications of Polyglycidol and Polyglycidol Derivatives in Diagnostics-Based Drug Carriers
Biocompatibility, long circulation time in the blood, the availability of many routes for
functionalization, and the suitability for controlled binding of various biomolecules makes polyglycidol
and its derivatives interesting for applications in medical diagnostics, both in vivo and in vitro.
There is great interest in contrast agents used in tissue imaging. Gd3+-loaded hyperbranched
polyglycidol with amine groups containing corona [103] and Fe3O4 superparamagnetic particles
protected by a hyperbranched pololyglycidol coating, used to stabilize particle circulation in the
blood, were found to be suitable for Magnetic Resonance Imaging (MRI) [104,105]. Hyperbranched
polyglycidol with sulfated corona, labeled with indocyanine green or indotricarbocyanine dyes, were
excellent agents for near-infrared fluorescence imaging [106,107].
Complex particles comprising a superparamagnetic iron oxide core coated with fluorescent
silica and protected with grafted hyperbranched polyglycidol constitute a new contrast agent
for MRI and optical imaging [108]. Tri-modal imaging systems were also developed based on
hyperbranched polyglycidol labeled with radioactive 111In, fluorescent Alexa dye, and Gd3+ for
MRI [109]. Hyperbranched polyglycidol with moieties chelating 67Ga/68Ga were studied as reagents
for positron emission tomography (PET) [110]. Gold nanorods coated with hyperbranched polyglycidol
with sulfated corona were used as a contrast agent for optoacoustic tomography, for the monitoring of
rheumatoid arthritis [111].
Polyglycidol with immobilized glucose oxidase is an essential component of biosensors for the
detection of glucose [112].
Basinska et al. developed a new type of diagnostic test based on the changes of electrophoretic
mobility in poly(styrene/α-tertbutoxy-ω-vinylbenzyl-polyglycidol) [113]. The test was dedicated for
determination of γ-globulins against Helicobacter pylori in the blood serum. The microspheres were
synthesized by emulsion copolymerization of styrene and α-tert-butoxy-ω-vinylbenzyl-polyglycidol.
Their interfacial layer enriched in polyglycidol allowed the covalent immobilization of antigens
complementary to antibodies against Helicobacter pylori, the proteins that are present in the blood
of infected patients. The polyglycidol-rich interfacial layer eliminated any adventitious protein
adsorption, allowing only attachment of antibodies against Helicobacter pylori by antigen–antibody
interactions. Since both microspheres and antibodies are electrically charged, the attachment of
antibodies affects the mobility of microspheres in an electric field.
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4. Conclusions
Synthesis of polyglycidol with moderate molar mass (about 30,000) and controlled topology (linear,
star-like, hyperbranched) does not pose a problem. Many methods were developed for synthesis of
various copolymers containing units of polyglycidol, polyethers (mainly poly(ethylene oxide) and
poly(propylene oxide)), polyesters (polylactide and poly(ε-caprolactone)), and polyolefins (styrene).
These copolymers could be functionalized with alkene and alkyne moieties, sulfate, amine, azide,
and carboxyl groups. They could be used for binding proteins and other biomolecules. Polyglycidols
modified with hydrophobic segments self-assemble into polymeric micelles, polymeric liposomes,
and other kinds of aggregates. When tethered to surfaces they modify the surface properties, making
the surfaces hydrophilic and antifouling. Amphiphilic derivatives of polyglycidol are promising
candidates for drug carriers and for contrast agents useful for various kinds of tissue imaging. However,
in spite of significant achievements in this field, there are still several problems to be solved.
Many functionalization processes and synthetic routes of drug carriers are multistep and for
large-scale pharmaceutical applications they are probably too expensive. Thus, a further search for
simpler modification routes is still needed. Knowledge of relations between topology and chemical
composition of polyglycidol-containing copolymers and their self-organization into polymeric micelles
and other types of nanoparticles is insufficient and still requires further studies. In spite of numerous
reports on protein–polyglycidol interactions, further investigation will be needed to give a detailed
explanation of these interactions at a molecular level. The possibility of synthesizing high molar mass
polyglycidol and polyglycidol-containing copolymers with biodegradable segments; i.e., copolymers
with mechanical properties appropriate for use as temporary implants replacing tendons and other
elastic tissue, has been insufficiently explored. The field is still quite far from being fully explored.
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